119 related articles for article (PubMed ID: 4560234)
1. [The role of brain dopamine].
Rybakowski J
Psychiatr Pol; 1972; 6(3):341-4. PubMed ID: 4560234
[No Abstract] [Full Text] [Related]
2. Dopamine and extrapyramidal motor function and dysfunction.
Hornykiewicz O
Res Publ Assoc Res Nerv Ment Dis; 1972; 50():390-415. PubMed ID: 4561070
[No Abstract] [Full Text] [Related]
3. Biochemical neuropathology of Parkinson's disease.
Javoy-Agid F; Ruberg M; Taquet H; Bokobza B; Agid Y; Gaspar P; Berger B; N'Guyen-Legros J; Alvarez C; Gray F
Adv Neurol; 1984; 40():189-98. PubMed ID: 6695594
[No Abstract] [Full Text] [Related]
4. [Biochemistry of the extrapyramidal system--from anatomical viewpoint].
Sano Y; Murase Y
Shinkei Kenkyu No Shimpo; 1968 Dec; 12(4):859-68. PubMed ID: 4898006
[No Abstract] [Full Text] [Related]
5. The effect of methiothepin on cerebral monoamine neurons.
Lloyd KG; Bartholini G
Adv Biochem Psychopharmacol; 1974; 10():305-9. PubMed ID: 4846546
[No Abstract] [Full Text] [Related]
6. [Dopaminergic conception of Parkinsonism and its treatment with L-DOPA].
Levin SL
Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(9):1418-26. PubMed ID: 4349303
[No Abstract] [Full Text] [Related]
7. Extrapyramidal dopamine regulation by cholecystokinin and its role in Parkinson's disease.
Diamond BI; Pasinetti G; Hitri A; Borison RL
Adv Neurol; 1984; 40():483-8. PubMed ID: 6695625
[No Abstract] [Full Text] [Related]
8. Drug-induced changes in brain dopamine and their relation to parkinsonism.
Vogt M
Sci Basis Med Annu Rev; 1970; ():276-91. PubMed ID: 4319923
[No Abstract] [Full Text] [Related]
9. Regional localization of histamine and histidine in the brain of the rhesus monkey.
Taylor KM; Gfeller E; Snyder SH
Brain Res; 1972 Jun; 41(1):171-9. PubMed ID: 4624724
[No Abstract] [Full Text] [Related]
10. [Biochemical bases for the treatment of Parkinson's syndrome with L-dopa].
Pletscher A; Bartholini G; Gey KF; Jenni A
Schweiz Med Wochenschr; 1970 May; 100(19):797-804. PubMed ID: 4924275
[No Abstract] [Full Text] [Related]
11. [Parkinson's syndrome. 2. Nuclei and extrapyramidal tracts].
Andén NE
Lakartidningen; 1970 Oct; 67(42):4807-12 passim. PubMed ID: 5478704
[No Abstract] [Full Text] [Related]
12. The metabolism of brain dopamine in human parkinsonism.
Hornykiewicz O
Riv Patol Nerv Ment; 1970 Oct; 91(5):281-6. PubMed ID: 5525774
[No Abstract] [Full Text] [Related]
13. Some remarks concerning the possible role of brain monoamines (dopamine, noradrenaline, serotonin) in mental disorders.
Hornykiewicz O
J Psychiatr Res; 1974; 11():249-53. PubMed ID: 4282386
[No Abstract] [Full Text] [Related]
14. [Biochemical bases of Parkinson disease].
Colucci d'Amato C; Puccini A; Cristillo A; Vizioli R
Recenti Prog Med; 1984 Oct; 75(10):889-901. PubMed ID: 6151219
[No Abstract] [Full Text] [Related]
15. The dopamine hypothesis of schizophrenia: a review.
Meltzer HY; Stahl SM
Schizophr Bull; 1976; 2(1):19-76. PubMed ID: 779020
[No Abstract] [Full Text] [Related]
16. Dopamine and adult neurogenesis.
Borta A; Höglinger GU
J Neurochem; 2007 Feb; 100(3):587-95. PubMed ID: 17101030
[TBL] [Abstract][Full Text] [Related]
17. The role of brain catecholamines in the regulation of ACTH secretion.
Van Loon GR
Adv Neurol; 1974; 5():479-86. PubMed ID: 4374068
[No Abstract] [Full Text] [Related]
18. Site-specific blockade of dopamine receptors by neuroleptic agents in human brain.
Borison RL; Fields JZ; Diamond BI
Neuropharmacology; 1981 Dec; 20(12B):1321-2. PubMed ID: 6119643
[No Abstract] [Full Text] [Related]
19. Experimental evaluation of L-dopa penetration in brain.
De la Torre JC; Mullan S
Trans Am Neurol Assoc; 1971; 96():227-9. PubMed ID: 5159088
[No Abstract] [Full Text] [Related]
20. Brain catecholamines and their metabolites in Parkinsonian patients. Treatment with levodopa alone or combined with a decarboxylase inhibitor.
Rinne UK; Sonninen V
Arch Neurol; 1973 Feb; 28(2):107-10. PubMed ID: 4683147
[No Abstract] [Full Text] [Related]
[Next] [New Search]
